Breaking News Instant updates and real-time market news.

2020-02-26 07:44:03 CDNA CareDx $25.04 / -1.5 (-5.65%) 07:44 02/26/20 02/26 07:44 02/26/20 07:44	CareDx announces publication on AlloSure's ability on ambiguous rejections CareDx announces that the American Journal of Transplantation published data on AlloSure's ability to differentiate ambiguous rejections, titled "High levels of dd-cfDNA identifies patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury." This landmark study, with 11 leading transplant centers, demonstrates that AlloSure is the only dd-cfDNA test that can discriminate clinical relevance of T-cell mediated rejection 1A or borderline biopsies. Currently, there is a lack of consensus on the impact of a TCMR 1A or borderline rejection diagnosis, and significant issues in interobserver pathology assessment. All patients in the study were diagnosed with TCMR 1A or borderline rejection. Those patients with AlloSure scores greater than 0.5% went on to have declining eGFR, a signal of deteriorating graft function and lower prediction of survival. However, those patients with AlloSure scores below 0.5% had almost no change in eGFR. The AJT publication illustrates how AlloSure can risk stratify the population with ambiguous rejections and enable personalized care for transplant patients.	27 Feb
CDNA CareDx $25.04 / -1.5 (-5.65%) 01/27/20 Piper Sandler CareDx gained first private payer decision for AlloSure, says Piper Sandler 12/19/19 Craig-Hallum Natera kidney test to be covered under Medicare in February, says Craig-Hallum 12/19/19 Piper Sandler CareDx should be bought on weakness from Natera coverage, says Piper 11/01/19 Piper Sandler CareDx continues to build 'moat around transplant,' says Piper Jaffray

2020-02-26 07:44:03

CDNA

CareDx

$25.04 / -1.5 (-5.65%)

07:44

02/26/20

02/26

07:44

02/26/20

07:44

CareDx announces publication on AlloSure's ability on ambiguous rejections

CareDx announces that the American Journal of Transplantation published data on AlloSure's ability to differentiate ambiguous rejections, titled "High levels of dd-cfDNA identifies patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury." This landmark study, with 11 leading transplant centers, demonstrates that AlloSure is the only dd-cfDNA test that can discriminate clinical relevance of T-cell mediated rejection 1A or borderline biopsies. Currently, there is a lack of consensus on the impact of a TCMR 1A or borderline rejection diagnosis, and significant issues in interobserver pathology assessment. All patients in the study were diagnosed with TCMR 1A or borderline rejection. Those patients with AlloSure scores greater than 0.5% went on to have declining eGFR, a signal of deteriorating graft function and lower prediction of survival. However, those patients with AlloSure scores below 0.5% had almost no change in eGFR. The AJT publication illustrates how AlloSure can risk stratify the population with ambiguous rejections and enable personalized care for transplant patients.

27
Feb

CDNA CareDx

$25.04 / -1.5 (-5.65%)

01/27/20 Piper Sandler: CareDx gained first private payer decision for AlloSure, says Piper Sandler

12/19/19 Craig-Hallum: Natera kidney test to be covered under Medicare in February, says Craig-Hallum

12/19/19 Piper Sandler: CareDx should be bought on weakness from Natera coverage, says Piper

11/01/19 Piper Sandler: CareDx continues to build 'moat around transplant,' says Piper Jaffray

TODAY'S FREE FLY STORIES

Options	ChargePoint Holdings call volume above normal and directionally bullish » 13:45 03/05/21 03/05 13:45 03/05/21 13:45 CHPT ChargePoint $22.45 / -1.7 (-7.04%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options CHPT ChargePoint $22.45 / -1.7 (-7.04%) 02/26/21 ChargePoint, Switchback Energy announce closing of business combination 02/25/21 Switchback Energy stockholders approve proposed combination with ChargePoint CHPT ChargePoint $22.45 / -1.7 (-7.04%) 03/02/21 Oppenheimer ChargePoint initiated with an Outperform at Oppenheimer 02/05/21 Roth Capital Switchback Energy Acquisition initiated with a Buy at Roth Capital CHPT ChargePoint $22.45 / -1.7 (-7.04%) 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal CHPT ChargePoint $22.45 / -1.7 (-7.04%) 03/01/21 Three new option listings and two option delistings on March 1st
Options	L Brands call volume above normal and directionally bullish » 13:25 03/05/21 03/05 13:25 03/05/21 13:25 LB L Brands $55.38 / +1.37 (+2.54%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LB L Brands $55.38 / +1.37 (+2.54%) 02/25/21 Alliance Data partners with Victoria's Secret on private label credit card 02/24/21 L Brands continuing to work toward separation of the two businesses 02/24/21 L Brands sees Q1 gross margin up 'significantly' 02/24/21 L Brands 'pleased' with February's results LB L Brands $55.38 / +1.37 (+2.54%) 02/26/21 Fly Intel: Top five analyst upgrades 02/26/21 Citi L Brands upgraded to Neutral from Sell at Citi 02/26/21 Morgan Stanley Morgan Stanley upgrades L Brands on improved post-COVID profitability 02/26/21 KeyBanc L Brands price target raised to $64 from $59 at KeyBanc LB L Brands $55.38 / +1.37 (+2.54%) 02/24/21 L Brands sees Q1 sales 'roughly flat' with last year's $2.6B 02/24/21 L Brands sees Q1 EPS 35c-45c, consensus 12c 02/24/21 L Brands reports Q4 EPS $3.03, consensus $2.91 02/24/21 Notable companies reporting after market close LB L Brands $55.38 / +1.37 (+2.54%) 11/18/20 Second investigation begins at Victoria's Secret over Epstein ties, NYT reports LB L Brands $55.38 / +1.37 (+2.54%) 02/26/21 Best Buy downgrade among today's top calls on Wall Street 02/24/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/19/20 Fly Intel: Wall Street's top stories for Thursday 05/20/21 L Brands - LB LB L Brands $55.38 / +1.37 (+2.54%) 02/26/21 Early notable gainers among liquid option names on February 26th 02/25/21 Early notable gainers among liquid option names on February 25th 02/04/21 Early notable gainers among liquid option names on February 4th 01/25/21 L Brands put volume heavy and directionally bearish
Technical Analysis	NASDAQ market internals summary » 13:17 03/05/21 03/05 13:17 03/05/21 13:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/04/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 13:16 03/05/21 03/05 13:16 03/05/21 13:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/04/21 NYSE market internals summary
Recommendations	ProsiebenSat price target raised to EUR 24 from EUR 20 at Societe Generale » 13:15 03/05/21 03/05 13:15 03/05/21 13:15 PBSFY ProsiebenSat $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PBSFY ProsiebenSat $0.00 / + (+0.00%) 03/01/21 Deutsche Bank ProsiebenSat price target raised to EUR 22 from EUR 14 at Deutsche Bank 03/01/21 Morgan Stanley ProsiebenSat price target raised to EUR 12 from EUR 10 at Morgan Stanley 02/09/21 JPMorgan ProsiebenSat price target raised to EUR 22.50 from EUR 21 at JPMorgan 01/22/21 Barclays ProsiebenSat price target raised to EUR 15 from EUR 12.50 at Barclays

General news	Action Economics Survey results » 13:15 03/05/21 03/05 13:15 03/05/21 13:15 Action Economics Survey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Prudential plc price target raised to 1,500 GBp at Societe Generale » 13:14 03/05/21 03/05 13:14 03/05/21 13:14 PUK Prudential plc $41.00 / +0.25 (+0.61%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PUK Prudential plc $41.00 / +0.25 (+0.61%) 02/26/21 JPMorgan Prudential plc price target raised to 1,437 GBp from 1,182 GBp at JPMorgan 02/26/21 Morgan Stanley Prudential plc price target raised to 1,638 GBp at Morgan Stanley 02/23/21 BofA Prudential plc downgraded to Neutral from Buy at BofA 02/23/21 BofA Prudential plc downgraded to Neutral from Buy at BofA
Recommendations	Ageas price target raised to EUR 58 from EUR 56.10 at Societe Generale » 13:14 03/05/21 03/05 13:14 03/05/21 13:14 AGESY Ageas $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AGESY Ageas $0.00 / + (+0.00%) 03/01/21 JPMorgan Ageas price target raised to EUR 55.87 from EUR 52.39 at JPMorgan 02/26/21 Berenberg Ageas price target raised to EUR 52.80 from EUR 51.90 at Berenberg 01/28/21 UBS Ageas price target raised to EUR 43.90 from EUR 40.50 at UBS 01/19/21 Morgan Stanley Ageas price target raised to EUR 51 from EUR 47.40 at Morgan Stanley
Recommendations	Knorr-Bremse price target lowered to EUR 124 from EUR 126 at Societe Generale » 13:13 03/05/21 03/05 13:13 03/05/21 13:13 KNRRY Knorr-Bremse $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KNRRY Knorr-Bremse $0.00 / + (+0.00%) 01/12/21 Deutsche Bank Knorr-Bremse price target raised to EUR 115 from EUR 107 at Deutsche Bank 12/11/20 Credit Suisse Knorr-Bremse price target raised to EUR 94 from EUR 89 at Credit Suisse 12/10/20 Berenberg Knorr-Bremse price target raised to EUR 111 from EUR 100 at Berenberg 11/25/20 JPMorgan Knorr-Bremse price target raised to EUR 110 from EUR 94 at JPMorgan
Recommendations	TransAlta price target lowered to C$12 from C$13 at National Bank » 13:13 03/05/21 03/05 13:13 03/05/21 13:13 TAC TransAlta $8.05 / -0.19 (-2.31%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TAC TransAlta $8.05 / -0.19 (-2.31%) 03/03/21 TransAlta sees 2021 adjusted EBITDA up 10% at midrange to C$960M-C$1.08B 02/04/21 TransAlta CEO Dawn Farrell to retire 02/01/21 TransAlta completes first of three CTG boiler conversions at Alberta facilities 12/23/20 TransAlta announces sale of assets to TransAlta Renewables TAC TransAlta $8.05 / -0.19 (-2.31%) 03/04/21 RBC Capital TransAlta price target raised to C$13 from C$11 at RBC Capital 03/04/21 TD Securities TransAlta price target raised to C$12.50 from C$11 at TD Securities 02/09/21 Scotiabank TransAlta price target raised to C$13.50 from C$12 at Scotiabank 01/27/21 National Bank TransAlta price target raised to C$13 from C$10 at National Bank TAC TransAlta $8.05 / -0.19 (-2.31%) 03/03/21 TransAlta reports Q4 FFO C$0.59 vs. C$0.67 a year ago 11/04/20 TransAlta reports Q3 FFO C$0.70 vs. C$0.87 a year ago TAC TransAlta $8.05 / -0.19 (-2.31%) 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021

Recommendations	NFI Group price target raised to C$34 from C$32 at National Bank » 13:12 03/05/21 03/05 13:12 03/05/21 13:12 NFYEF NFI Group $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NFYEF NFI Group $0.00 / + (+0.00%) 13:05 Today BMO Capital NFI Group price target lowered to C$38 from C$40 at BMO Capital 11:19 Today Scotiabank NFI Group price target raised to C$35 from C$34 at Scotiabank 03/03/21 TD Securities NFI Group price target lowered to C$34 from C$35 at TD Securities 03/02/21 BMO Capital NFI Group price target lowered to C$40 from C$42 at BMO Capital
Recommendations	Kinaxis price target lowered to C$225 from C$250 at National Bank » 13:12 03/05/21 03/05 13:12 03/05/21 13:12 KXSCF Kinaxis $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KXSCF Kinaxis $0.00 / + (+0.00%) 13:06 Today RBC Capital Kinaxis price target lowered to C$190 from C$260 at RBC Capital 13:04 Today BMO Capital Kinaxis price target lowered to C$170 from C$250 at BMO Capital 11:17 Today Scotiabank Kinaxis price target lowered to C$179 from C$241 at Scotiabank 11:15 Today TD Securities Kinaxis price target lowered to C$165 from C$255 at TD Securities
Recommendations	Element Fleet price target raised to C$19 from C$18 at National Bank » 13:11 03/05/21 03/05 13:11 03/05/21 13:11 ELEEF Element Fleet $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ELEEF Element Fleet $0.00 / + (+0.00%) 01/13/21 Element Fleet appoints Frank Ruperto as CFO ELEEF Element Fleet $0.00 / + (+0.00%) 03/04/21 RBC Capital Element Fleet price target raised to C$18 from C$17 at RBC Capital 03/01/21 BMO Capital Element Fleet price target lowered to C$16 from C$17 at BMO Capital 10/28/20 BMO Capital Element Fleet price target raised to C$17 from C$13 at BMO Capital 10/28/20 Raymond James Element Fleet price target raised to C$14.50 from C$12.25 at Raymond James
Hot Stocks	Aqua Metals meets Nasdaq requirements for continued listing » 13:09 03/05/21 03/05 13:09 03/05/21 13:09 AQMS Aqua Metals $3.67 / +0.12 (+3.38%) Aqua Metals announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research AQMS Aqua Metals $3.67 / +0.12 (+3.38%) 03/02/21 Aqua Metals appoints Molly Zhang, Edward Smith to board 02/23/21 Aqua Metals files provisional patent for lithium-ion battery recycling 02/17/21 Aqua Metals invests $2M in LiNiCo 02/17/21 Comstock Mining secures majority interest in LiNiCo AQMS Aqua Metals $3.67 / +0.12 (+3.38%) 06:08 Today H.C. Wainwright Aqua Metals initiated with a Buy at H.C. Wainwright 03/12/20 Oppenheimer Aqua Metals price target lowered to $2 from $9 at Oppenheimer
Recommendations	Cineplex price target raised to C$17 from C$14 at National Bank » 13:09 03/05/21 03/05 13:09 03/05/21 13:09 CPXGF Cineplex $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research On The Fly CPXGF Cineplex $0.00 / + (+0.00%) 02/22/21 CIBC Cineplex price target raised to C$14 from C$12 at CIBC 02/12/21 BMO Capital Cineplex price target raised to C$12 from C$7 at BMO Capital 02/12/21 Canaccord Cineplex price target raised to C$10.50 from C$8.50 at Canaccord 02/12/21 RBC Capital Cineplex price target raised to C$9 from C$8 at RBC Capital CPXGF Cineplex $0.00 / + (+0.00%) 10/05/20 Fly Intel: Wall Street's top stories at midday

Recommendations	Peyto Exploration price target raised to C$7 from C$6.25 at RBC Capital » 13:08 03/05/21 03/05 13:08 03/05/21 13:08 PEYUF Peyto Exploration $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PEYUF Peyto Exploration $0.00 / + (+0.00%) 03/04/21 BMO Capital Peyto Exploration price target raised to C$6 from C$5.75 at BMO Capital 03/04/21 Scotiabank Peyto Exploration price target raised to C$6.50 from C$5.50 at Scotiabank 02/19/21 TD Securities Peyto Exploration price target raised to C$6.50 from C$3.50 at TD Securities 02/19/21 National Bank Peyto Exploration price target raised to C$8 from C$3.50 at National Bank
Recommendations	Nuvista Energy price target raised to C$3 from C$2.25 at RBC Capital » 13:08 03/05/21 03/05 13:08 03/05/21 13:08 NUVSF Nuvista Energy $0.00 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NUVSF Nuvista Energy $0.00 / + (+0.00%) 11:45 Today Desjardins Nuvista Energy price target raised to C$3 from C$1.75 at Desjardins 03/04/21 Canaccord Nuvista Energy price target raised to C$2.25 from C$2 at Canaccord 03/04/21 Stifel Nuvista Energy price target raised to C$2.50 from C$2.25 at Stifel 03/04/21 CIBC Nuvista Energy price target raised to C$2.50 from C$2.25 at CIBC
Recommendations	MEG Energy price target raised to C$9 from C$8.50 at RBC Capital » 13:07 03/05/21 03/05 13:07 03/05/21 13:07 MEGEF MEG Energy $0.00 / + (+0.00%) RBC Capital analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MEGEF MEG Energy $0.00 / + (+0.00%) 11:38 Today Desjardins MEG Energy price target raised to C$7 from C$4 at Desjardins 03/04/21 Raymond James MEG Energy price target raised to C$8.50 from C$7.50 at Raymond James 03/04/21 BMO Capital MEG Energy price target raised to C$8 from C$6.50 at BMO Capital 03/04/21 TD Securities MEG Energy price target raised to C$7 from C$5.50 at TD Securities
Recommendations	Kinaxis price target lowered to C$190 from C$260 at RBC Capital » 13:06 03/05/21 03/05 13:06 03/05/21 13:06 KXSCF Kinaxis $0.00 / + (+0.00%) RBC Capital analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KXSCF Kinaxis $0.00 / + (+0.00%) 13:04 Today BMO Capital Kinaxis price target lowered to C$170 from C$250 at BMO Capital 11:17 Today Scotiabank Kinaxis price target lowered to C$179 from C$241 at Scotiabank 11:15 Today TD Securities Kinaxis price target lowered to C$165 from C$255 at TD Securities 08:00 Today Stifel Kinaxis upgraded to Buy from Hold at Stifel
Recommendations	Freehold Royalties price target raised to C$10 from C$9 at RBC Capital » 13:06 03/05/21 03/05 13:06 03/05/21 13:06 FRHLF Freehold Royalties $0.00 / + (+0.00%) RBC Capital analyst Luke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FRHLF Freehold Royalties $0.00 / + (+0.00%) 12:58 Today BMO Capital Freehold Royalties price target raised to C$9 from C$6 at BMO Capital 11:16 Today Scotiabank Freehold Royalties price target raised to C$8 from C$7.25 at Scotiabank 11:13 Today TD Securities Freehold Royalties price target raised to C$9.50 from C$9 at TD Securities 02/19/21 National Bank Freehold Royalties price target raised to C$9 from C$7.50 at National Bank

Recommendations	Cominar REIT price target raised to C$10 from C$9 at RBC Capital » 13:05 03/05/21 03/05 13:05 03/05/21 13:05 CMLEF Cominar REIT $0.00 / + (+0.00%) RBC Capital analyst Pammi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CMLEF Cominar REIT $0.00 / + (+0.00%) 11:31 Today Desjardins Cominar REIT price target raised to C$9.75 from C$9 at Desjardins 03/04/21 Scotiabank Cominar REIT price target raised to C$10.50 from C$9.75 at Scotiabank 03/04/21 TD Securities Cominar REIT price target raised to C$9.50 from C$9 at TD Securities 11/09/20 RBC Capital Cominar REIT price target raised to C$9 from C$8.50 at RBC Capital
Recommendations	NFI Group price target lowered to C$38 from C$40 at BMO Capital » 13:05 03/05/21 03/05 13:05 03/05/21 13:05 NFYEF NFI Group $0.00 / + (+0.00%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NFYEF NFI Group $0.00 / + (+0.00%) 11:19 Today Scotiabank NFI Group price target raised to C$35 from C$34 at Scotiabank 03/03/21 TD Securities NFI Group price target lowered to C$34 from C$35 at TD Securities 03/02/21 BMO Capital NFI Group price target lowered to C$40 from C$42 at BMO Capital 03/02/21 National Bank NFI Group price target lowered to C$32 from C$33 at National Bank
Recommendations	Kinaxis price target lowered to C$170 from C$250 at BMO Capital » 13:04 03/05/21 03/05 13:04 03/05/21 13:04 KXSCF Kinaxis $0.00 / + (+0.00%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KXSCF Kinaxis $0.00 / + (+0.00%) 11:17 Today Scotiabank Kinaxis price target lowered to C$179 from C$241 at Scotiabank 11:15 Today TD Securities Kinaxis price target lowered to C$165 from C$255 at TD Securities 08:00 Today Stifel Kinaxis upgraded to Buy from Hold at Stifel 11/06/20 RBC Capital Kinaxis price target raised to C$260 from C$240 at RBC Capital
General news	Baker Hughes Rig Count North America data reported » 13:04 03/05/21 03/05 13:04 03/05/21 13:04 Week of 3/5 Baker Hughes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Baker Hughes reports U.S. rig count up 1 to 403 rigs » 13:04 03/05/21 03/05 13:04 03/05/21 13:04 BKR Baker Hughes $23.73 / -0.29 (-1.21%) Baker Hughes reports that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BKR Baker Hughes $23.73 / -0.29 (-1.21%) 13:00 Today Baker Hughes reports U.S. rig count up 1 to 403 rigs 03/02/21 Baker Hughes announces transaction structure for Akastor joint venture 03/02/21 Baker Hughes, Akastor to create offshore drilling equipment joint venture 02/26/21 Baker Hughes reports U.S. rig count up 5 to 402 rigs BKR Baker Hughes $23.73 / -0.29 (-1.21%) 02/01/21 Piper Sandler Baker Hughes price target raised to $30 from $26 at Piper Sandler 01/22/21 Morgan Stanley Baker Hughes price target raised to $26 after earnings at Morgan Stanley 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays BKR Baker Hughes $23.73 / -0.29 (-1.21%) 01/21/21 Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open BKR Baker Hughes $23.73 / -0.29 (-1.21%) 02/24/21 Baker Hughes, AXA, 16 others wind down work on Nord Stream 2, Reuters says 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $23.73 / -0.29 (-1.21%) 10/21/20 Fly Intel: Pre-market Movers

Events

Earnings calls, analyst events, roadshows and more

Today at 15:00

Fed Reserve Bank President Speaks at Virtual Event Government Event

Virtual Meeting
Today at 15:00

Consumer Credit M/M: January 2021 Government Event
INFU
2021-03-08 at 00:00

InfuSystem - INFU Conference Calls
2021-03-08 at 00:00

Media, Internet and Telecom Virtual Conference Conferences

Virtual Conference
2021-03-08 at 00:00

Global Property Virtual Conference Conferences

Virtual Conference
RGEN
2021-03-08 at 00:00

Repligen Firm Sponsored Meetings

Virtual Meeting
PNW
2021-03-08 at 00:00

Pinnacle West Firm Sponsored Meetings

Virtual Meeting
GBT
2021-03-08 at 00:00

Global Blood Therapeutics Firm Sponsored Meetings

Virtual Meeting
RBA
2021-03-08 at 00:00

Ritchie Bros. Firm Sponsored Meetings

Virtual Meeting
ITRI
2021-03-08 at 00:00

Itron Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan Priced at: $46.50 3.9M Shares INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair Priced at: $44.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	NCLH X NCLH Norwegian Cruise Line Spot Secondary Managers: Goldman Sachs Priced at: $29.85 47.6M Shares

Mon	No deals
Tues	No deals
Wed	FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

CareDx announces publication on AlloSure's ability on ambiguous rejections

TODAY'S FREE FLY STORIES

Get Full Fly Access